Low free testosterone levels predict disease reclassification in men with prostate cancer undergoing active surveillance

作者: Ignacio F San Francisco , Pablo A Rojas , William C DeWolf , Abraham Morgentaler , None

DOI: 10.1111/BJU.12682

关键词:

摘要: Objective To determine whether total testosterone and free levels predict disease reclassification in a cohort of men with prostate cancer (PCa) on active surveillance (AS). Patients Methods Total concentrations were determined at the time began AS protocol. Statistical analysis was performed using Student's t-test chi-squared test to compare groups. Odds ratios (ORs) 95% confidence intervals (CIs) obtained univariate logistic regression. Receiver–operator characteristic curves generated investigated thresholds. Kaplan–Meier used estimate reclassification. A Cox proportional hazard regression model for multivariate analysis. Results A 154 included cohort, whom 54 (35%) progressed treatment. Men who had significantly lower than those not reclassified (0.75 vs 1.02 ng/dL, P = 0.03). <0.45 ng/dL higher rate patients ≥0.45 (P 0.032). Free associated several-fold increase risk (OR 4.3, CI 1.25–14.73). Multivariate showed that family history PCa independent predictors reclassification. Conclusions Free during AS. moderately severe reductions level are increased

参考文章(38)
Juan Morote, Jordi Ropero, Jacques Planas, Juan M. Bastarós, Gueisy Delgado, José Placer, Anna Celma, Inés M. de Torres, Joan Carles, Jaume Reventós, Andreas Doll, Metabolic syndrome increases the risk of aggressive prostate cancer detection BJU International. ,vol. 111, pp. 1031- 1036 ,(2013) , 10.1111/J.1464-410X.2012.11406.X
Eduardo García-Cruz, Marta Piqueras, Jorge Huguet, Lluis Peri, Laura Izquierdo, Mireia Musquera, Agustin Franco, Ricardo Alvarez-Vijande, Maria Jose Ribal, Antonio Alcaraz, Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment. BJUI. ,vol. 110, ,(2012) , 10.1111/J.1464-410X.2012.11232.X
Albert El Hajj, Guillaume Ploussard, Alexandre de la Taille, Yves Allory, Dimitri Vordos, Andras Hoznek, Claude Clément Abbou, Laurent Salomon, Analysis of outcomes after radical prostatectomy in patients eligible for active surveillance (PRIAS). BJUI. ,vol. 111, pp. 53- 59 ,(2013) , 10.1111/J.1464-410X.2012.11276.X
Martin Andreas Røder, Ib Jarle Christensen, Kasper D. Berg, Lisa Gruschy, Klaus Brasso, Peter Iversen, Serum testosterone level as a predictor of biochemical failure after radical prostatectomy for localized prostate cancer. BJUI. ,vol. 109, pp. 520- 524 ,(2012) , 10.1111/J.1464-410X.2011.10335.X
Bo Dai, YuanYuan Qu, YunYi Kong, DingWei Ye, XuDong Yao, ShiLin Zhang, ChaoFu Wang, HaiLiang Zhang, WeiYi Yang, None, Low pretreatment serum total testosterone is associated with a high incidence of Gleason score 8-10 disease in prostatectomy specimens: data from ethnic Chinese patients with localized prostate cancer BJU International. ,vol. 110, pp. E667- E672 ,(2012) , 10.1111/J.1464-410X.2012.11465.X
Griet Vanbillemont, Veerle Bogaert, Dirk De Bacquer, Bruno Lapauw, Stefan Goemaere, Kaatje Toye, Kristel Van Steen, Youri Taes, Jean-Marc Kaufman, Polymorphisms of the SHBG gene contribute to the interindividual variation of sex steroid hormone blood levels in young, middle-aged and elderly men. Clinical Endocrinology. ,vol. 70, pp. 303- 310 ,(2009) , 10.1111/J.1365-2265.2008.03365.X
Eduardo García‐Cruz, Asier Leibar‐Tamayo, Javier Romero, Marta Piqueras, Pilar Luque, Oscar Cardeñosa, Antonio Alcaraz, Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction The Journal of Sexual Medicine. ,vol. 10, pp. 2529- 2538 ,(2013) , 10.1111/JSM.12265
Luigi Mearini, Alessandro Zucchi, Elisabetta Nunzi, Tommaso Villirillo, Vittorio Bini, Massimo Porena, Low serum testosterone levels are predictive of prostate cancer World Journal of Urology. ,vol. 31, pp. 247- 252 ,(2013) , 10.1007/S00345-011-0793-X
Ernani Luis Rhoden, Charles Edison Riedner, Abraham Morgentaler, The Ratio of Serum Testosterone-to-Prostate Specific Antigen Predicts Prostate Cancer in Hypogonadal Men The Journal of Urology. ,vol. 179, pp. 1741- 1745 ,(2008) , 10.1016/J.JURO.2008.01.045